Acute-phase proteins and other systemic responses to inflammation

New England Journal of Medicine

Volumn 340, Issue 6, 1999, Pages 448-454

  Gabay, Cem ^a   Kushner, Irving ^b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMYLOID A PROTEIN; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ACUTE PHASE RESPONSE; ANEMIA; CYTOKINE RELEASE; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HUMAN; HYPOALBUMINEMIA; INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ACUTE-PHASE PROTEINS; ACUTE-PHASE REACTION; C-REACTIVE PROTEIN; CYTOKINES; HUMANS; INFLAMMATION;

EID: 0033545342     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199902113400607     Document Type: Review

References (65)

1. Tillett WS, Francis T Jr. Serological reactions in pneumonia with non-protein somatic fraction of pneumococcus. J Exp Med 1930;52:561-71.
2. Kushner I. Regulation of the acute phase response by cytokines. Perspect Biol Med 1993;36:611-22.
3. Dinarello CA. Interleukin-1 and the pathogenesis of the acute-phase response. N Engl J Med 1984;311:1413-8.
4. Morley JJ, Kushner I. Serum C-reactive protein levels in disease. Ann N Y Acad Sci 1982;389:406-18.
5. Gitlin JD, Colten HR. Molecular biology of the acute phase plasma proteins. In: Pick E, Landy M, eds. Lymphokines. Vol. 14. San Diego, Calif.: Academic Press, 1987:123-53.
6. Maes M, Delange J, Ranjan R, et al. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res 1997;66:1-11.
7. Wigmore SJ, Fearon KCH, Maingay JP, Lai PBS, Ross JA. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol 1997;273:E720-E726.
8. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A 1987;84:7251-5.
9. Fattori E, Cappelletti M, Costa P, et al. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 1994;180:1243-50.
10. Zheng H, Fletcher D, Kozak W, et al. Resistance to fever induction and impaired acute-phase response in interleukin-1 β-deficient mice. Immunity 1995;3:9-19.
11. Richards CD, Langdon C, Pennica D, Gauldie J. Murine cardiotrophin-1 stimulates the acute-phase response in rat hepatocytes and H35 hepatoma cells. J Interferon Cytokine Res 1996;16:69-75.
12. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
13. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095-147.
14. Xing Z, Gauldie J, Cox G, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998;101:311-20.
15. Mackiewicz A, Speroff T, Ganapathi MK, Kushner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 1991;146:3032-7.
16. Gabay C, Smith MF, Eidlen D, Arend WP. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest 1997;99:2930-40.
17. Loyer P, Ilyin G, Abdel Razzak Z, et al. Interleukin 4 inhibits the production of some acute-phase proteins by human hepatocytes in primary culture. FEBS Lett 1993-336.215-20.
18. Mackiewicz A, Shooltink H, Heinrich PC, Rose-John S. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J Immunol 1992;149:2021-7.
19. Baumann H, Richard C, Gauldie J. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J Immunol 1987;139:4122-8.
20. Campos SP, Wang Y, Koj A, Baumann H. Insulin cooperates with IL-1 in regulating expression of α1-acid glycoprotein gene in rat hepatoma cells. Cytokine 1994;6:485-92.
21. Jiang S-L, Samols C, Rzewnicki D, et al. Kinetic modeling and mathematical analysis indicate that acute phase gene expression in Hep 3B cells is regulated by both transcriptional and posttranscriptional mechanisms. J Clin Invest 1995;95:1253-61.
22. Rogers JT, Bridges KR, Durmowicz GP, Glass J, Auron PE, Munro HN. Translational control during the acute phase response: ferritin synthesis in response to interleukin-1. J Biol Chem 1990;265:14572-8.
23. Van Dijk W, Mackiewicz A. Interleukin-6-type cytokine-induced changes in acute phase protein glycosylation. Ann N Y Acad Sci 1995;762: 319-30.
24. de Graaf TW, Van der Stelt ME, Anbergen MG, van Dijk W. Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotcin (orosomucoid) in human sera. J Exp Med 1993;177:657-66.
25. Dube R, Rook GAW, Steele J, et al. Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut 1990;31:431-4.
26. Yue CC, Muller-Greven J, Dailey P, Lozanski G, Anderson V, Macintyre S. Identification of a C-reactive protein binding site in two hepatic carboxylesterases capable of retaining C reactive protein within the endoplasmic reticulum. J Biol Chem 1996;271:22245-50.
27. Dinarello CA. Cytokines as endogenous pyrogens. In: Mackowiak PA, ed. Fever: basic mechanisms and management. 2nd ed. Philadelphia: Lippincott-Raven, 1997:87-116.
28. Goldbach JM, Roth J, Zeisberger E. Fever suppression by subdiaphragmatic vagotomy in guinea pigs depends on the route of pyrogen administration. Am J Physiol 1997;272:R675-R681.
29. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-62.
30. Sarraf P, Frederich RC, Turner EM, et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997;185:171-5.
31. Means RT Jr. Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia. Stem Cells 1995;13:32-7.
32. Weiss G, Bogdan C, Hentze MW. Pathways for the regulation of mac rophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol 1997;158:420-5.
33. Zeidler C, Kanz L, Hurkuck KL, et al. In vivo effects of interleukin-6 on thrombopoiesis in healthy and irradiated primates. Blood 1992;80-2740-5.
34. Tai H, Miyaura C, Pilbeam CC, et al. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation. Endocrinology 1997;138:2372-9.
35. Moldawer LL, Copeland EM III. Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options. Cancer 1997;79:1828-39.
36. Hardardottir I, Grunfeld C, Feingold KR. Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol 1994;5:207-15.
37. Wolf M, Bohm S, Brand M, Kreymann G. Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor a inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells. Eur J Endocrinol 1996; 135:729-37.
38. De Benedetti F, Alonzi T, Moretta A, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-1: a model for stunted growth in children with chronic inflammation. J Clin Invest 1997;99:643-50.
39. Kushner I. Semantics, inflammation, cytokines and common sense. Cytokine Growth Factor Rev 1998;9:191-6.
40. Volanakis JE. Acute phase proteins in rheumatic disease. In: Koopman WJ, ed. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. Baltimore: Williams & Wilkins, 1997:505-14.
41. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992; 4:361-8.
42. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-20.
43. Ahmed N, Thorley R, Xia D, Samols D, Webster RO. Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis. Am J Respir Crit Care Med 1996;153:1141-7.
44. Xia D, Samols D. Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc Natl Acad Sci U S A 1997;94:2575-80.
45. Zouki C, Beauchamp M, Baron C, Filep JG. Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. J Clin Invest 1997;100:522-9.
46. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 1996; 26:427-35.
47. Banka CL, Yuan T, de Beer MC, Kindy M, Curtiss LK, de Beer FC. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux J Lipid Res 1995;36:1058-65.
48. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanism - oxidation, inflammation, and genetics. Circulation 1995;91: 2488-96.
49. Kilpatrick L, McCawley L, Nachiappan V, et al. α-1-Antichymotrypsin inhibits the NADPH oxidase-enzyme complex in phorbol ester-stimulated neutrophil membranes. J Immunol 1992;149:3059-65.
50. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993;91:977-85.
51. Borish L, King MS, Mascali JJ, Johnson S, Coll B, Rosenwasser LJ. Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production. Inflammation 1992;16:471-84.
52. Kluger MJ, Kozak W, Conn CA, Leon LR, Soszynski D. The adaptive value of fever. In: Mackowiak PA, ed. Fever: basic mechanisms and management. 2nd ed. Philadelphia: Lippincott-Raven, 1997:255-66.
53. Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 1996;24:163-72.
54. van Leeuwen MA, van der Heijde DMFM, van Rijswijk MH, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis: a comparison of radiologie damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994;21:425-9
55. Pepys MB, Lanham JG, De Beer FC. C-reactive protein in SLE. Clin Rheum Dis 1982;8:91-103.
56. ter Borg EJ, Horst G, Limburg PC, van Rijswijk MH, Kallenberg CGM. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 1990;17:1642-8.
57. Moutsopoulos HM, Mavridis AK, Acritidis NC, Avgerinos PC. High C reactive protein response in lupus polyarthritis. Clin Exp Rheumatol 1983;1:53-5.
58. Spector TD, Hart DJ, Nandra D, et al. Low level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum 1997;40:723-7.
59. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997;349:462-6.
60. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9. [Erratum, N Engl J Med 1997;337:356.]
61. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9. [Erratum, N Engl J Med 1997;337:356.]
62. May LT, Viguet H, Kenney JS, Ida N, Allison AC, Sehgal PB. High levels of "complexed" interleukin-6 in human blood. J Biol Chem 1992; 267:19698-704.
63. Arend WP, Malyak M, Smith MF Jr, et al. Binding of IL-1α, IL-1β, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol 1994;153:4766-74.
64. Gabay C, Cakir N, Moral F, et al. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly-higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 1997;24:303-8.
65. Gabay C, Gay-Croisier F, Roux-Lombard P, et al. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis: a biologic marker of disease activity with a possible role in the lack of acute phase protein response. Arthritis Rheum 1994;37:1744-51.